Atlas Trials

Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T Therapy

Clinical trial NCT04614987 · TERMINATED

Trial details

NCT number
NCT04614987
Sponsor
Washington University School of Medicine
Status
TERMINATED
Study type
OBSERVATIONAL
Neurotoxicity
Start date
2021-02-25
Primary completion
2023-09-13
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.